The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...

Chicago-based Meitheal Pharmaceuticals, along with its Chinese parent, was busy in 2024, adding both biosimilar drugs and ...

A consortium including scientists from the Tropical Institute at LMU University Hospital has demonstrated the effectiveness ...

Washington researchers and care providers are struggling to keep up with new chemicals in the region’s illicit drug supply.

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included in the historic 2022 drug law ...

Carbapenems are last-resort antibiotics for treating bacterial infections. A study shows how zinc plays a role in drug-resistant bacteria.